- Report
- July 2025
- 134 Pages
Global
From €4087EUR$4,650USD£3,535GBP
- Report
- January 2025
- 100 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 193 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- September 2025
- 250 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 93 Pages
Global
From €4922EUR$5,600USD£4,258GBP
- Report
- September 2025
- 382 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2637EUR$3,000USD£2,281GBP
- Report
- December 2024
- 159 Pages
Global
From €3472EUR$3,950USD£3,003GBP
- Report
- March 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,052GBP
- Report
- November 2024
- 39 Pages
Global
From €3512EUR$3,995USD£3,037GBP
- Report
- July 2025
- 150 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 189 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 191 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1758EUR$2,000USD£1,521GBP
- Report
- October 2024
- 318 Pages
Global
From €6988EUR$7,950USD£6,044GBP
From €4307EUR$4,900USD£3,725GBP
- Report
- October 2024
- 200 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- June 2025
- 209 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- June 2025
- 400 Pages
Global
From €4350EUR$4,949USD£3,763GBP

The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more